Beijing SL Pharmaceutical Co., Ltd. (002038.SZ)
CNY 7.26
(0.41%)
CNY 7.26
(0.41%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 420.68 Million CNY | 6.07% |
| 2022 | 396.6 Million CNY | -8.67% |
| 2021 | 434.23 Million CNY | 5.89% |
| 2020 | 410.09 Million CNY | 1.57% |
| 2019 | 403.75 Million CNY | -14.05% |
| 2018 | 469.73 Million CNY | 64.43% |
| 2017 | 285.67 Million CNY | 88.95% |
| 2016 | 151.19 Million CNY | 1.88% |
| 2015 | 148.4 Million CNY | 7.6% |
| 2014 | 137.92 Million CNY | 12.05% |
| 2013 | 123.08 Million CNY | 17.04% |
| 2012 | 105.17 Million CNY | 108.19% |
| 2011 | 50.51 Million CNY | 35.72% |
| 2010 | 37.22 Million CNY | 1.28% |
| 2009 | 36.75 Million CNY | 41.86% |
| 2008 | 25.9 Million CNY | -25.36% |
| 2007 | 34.7 Million CNY | -1.98% |
| 2006 | 35.41 Million CNY | 51.19% |
| 2005 | 23.42 Million CNY | -17.47% |
| 2004 | 28.37 Million CNY | -22.84% |
| 2003 | 36.78 Million CNY | 113.5% |
| 2002 | 17.22 Million CNY | 58.96% |
| 2001 | 10.83 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 432.24 Million CNY | 2.75% |
| 2024 Q3 | 273.44 Million CNY | 31.32% |
| 2024 Q2 | 208.22 Million CNY | -51.83% |
| 2023 FY | 420.68 Million CNY | 6.07% |
| 2023 Q3 | 374.87 Million CNY | -4.89% |
| 2023 Q2 | 394.14 Million CNY | -3.05% |
| 2023 Q4 | 420.68 Million CNY | 12.22% |
| 2023 Q1 | 406.52 Million CNY | 2.5% |
| 2022 Q4 | 396.6 Million CNY | -6.93% |
| 2022 Q2 | 408.72 Million CNY | -0.07% |
| 2022 Q1 | 409.03 Million CNY | -5.8% |
| 2022 FY | 396.6 Million CNY | -8.67% |
| 2022 Q3 | 426.12 Million CNY | 4.26% |
| 2021 Q3 | 411.23 Million CNY | -3.13% |
| 2021 Q4 | 434.23 Million CNY | 5.59% |
| 2021 Q1 | 409.78 Million CNY | -0.07% |
| 2021 FY | 434.23 Million CNY | 5.89% |
| 2021 Q2 | 424.49 Million CNY | 3.59% |
| 2020 FY | 410.09 Million CNY | 1.57% |
| 2020 Q4 | 410.09 Million CNY | 2.78% |
| 2020 Q2 | 394.56 Million CNY | 4.85% |
| 2020 Q1 | 376.3 Million CNY | -6.8% |
| 2020 Q3 | 398.98 Million CNY | 1.12% |
| 2019 Q2 | 441.52 Million CNY | -2.68% |
| 2019 Q3 | 448.93 Million CNY | 1.68% |
| 2019 Q4 | 403.75 Million CNY | -10.06% |
| 2019 FY | 403.75 Million CNY | -14.05% |
| 2019 Q1 | 453.69 Million CNY | -3.41% |
| 2018 Q3 | 276.79 Million CNY | -1.28% |
| 2018 Q1 | 282.17 Million CNY | -1.22% |
| 2018 FY | 469.73 Million CNY | 64.43% |
| 2018 Q2 | 280.37 Million CNY | -0.64% |
| 2018 Q4 | 469.73 Million CNY | 69.71% |
| 2017 Q2 | 153.69 Million CNY | -2.2% |
| 2017 Q1 | 157.15 Million CNY | 3.95% |
| 2017 FY | 285.67 Million CNY | 88.95% |
| 2017 Q4 | 285.67 Million CNY | 45.63% |
| 2017 Q3 | 196.15 Million CNY | 27.63% |
| 2016 Q1 | 152.77 Million CNY | 2.94% |
| 2016 FY | 151.19 Million CNY | 1.88% |
| 2016 Q4 | 151.19 Million CNY | 15.95% |
| 2016 Q2 | 135.73 Million CNY | -11.15% |
| 2016 Q3 | 130.39 Million CNY | -3.94% |
| 2015 Q3 | 119.84 Million CNY | -6.55% |
| 2015 Q4 | 148.4 Million CNY | 23.83% |
| 2015 Q1 | 138.86 Million CNY | 0.68% |
| 2015 Q2 | 128.25 Million CNY | -7.64% |
| 2015 FY | 148.4 Million CNY | 7.6% |
| 2014 Q4 | 137.92 Million CNY | 18.08% |
| 2014 FY | 137.92 Million CNY | 12.05% |
| 2014 Q2 | 105.39 Million CNY | -6.99% |
| 2014 Q3 | 116.8 Million CNY | 10.82% |
| 2014 Q1 | 113.31 Million CNY | -7.94% |
| 2013 Q2 | 80.86 Million CNY | -1.44% |
| 2013 Q1 | 82.04 Million CNY | -21.99% |
| 2013 FY | 123.08 Million CNY | 17.04% |
| 2013 Q4 | 123.08 Million CNY | 78.35% |
| 2013 Q3 | 69.01 Million CNY | -14.65% |
| 2012 Q3 | 74.34 Million CNY | 10.64% |
| 2012 Q2 | 67.2 Million CNY | 12.95% |
| 2012 Q1 | 59.49 Million CNY | 17.78% |
| 2012 FY | 105.17 Million CNY | 108.19% |
| 2012 Q4 | 105.17 Million CNY | 41.45% |
| 2011 Q3 | 78.15 Million CNY | 6.48% |
| 2011 Q1 | 50.3 Million CNY | 35.15% |
| 2011 FY | 50.51 Million CNY | 35.72% |
| 2011 Q2 | 73.39 Million CNY | 45.9% |
| 2011 Q4 | 50.51 Million CNY | -35.36% |
| 2010 Q1 | 49.7 Million CNY | 35.25% |
| 2010 FY | 37.22 Million CNY | 1.28% |
| 2010 Q4 | 37.22 Million CNY | -36.76% |
| 2010 Q3 | 58.85 Million CNY | 2.88% |
| 2010 Q2 | 57.21 Million CNY | 15.11% |
| 2009 Q3 | 40.02 Million CNY | 9.9% |
| 2009 Q2 | 36.42 Million CNY | -4.65% |
| 2009 FY | 36.75 Million CNY | 41.86% |
| 2009 Q1 | 38.2 Million CNY | 47.46% |
| 2009 Q4 | 36.75 Million CNY | -8.19% |
| 2008 Q4 | 25.9 Million CNY | -41.47% |
| 2008 Q3 | 44.26 Million CNY | 13.28% |
| 2008 Q2 | 39.07 Million CNY | 2.59% |
| 2008 Q1 | 38.08 Million CNY | 9.72% |
| 2008 FY | 25.9 Million CNY | -25.36% |
| 2007 FY | 34.7 Million CNY | -1.98% |
| 2007 Q1 | 30.26 Million CNY | -14.52% |
| 2007 Q4 | 34.7 Million CNY | 37.98% |
| 2007 Q3 | 25.15 Million CNY | -31.13% |
| 2007 Q2 | 36.52 Million CNY | 20.67% |
| 2006 Q3 | 33.81 Million CNY | 13.22% |
| 2006 Q1 | 28.44 Million CNY | 21.46% |
| 2006 Q4 | 35.41 Million CNY | 4.71% |
| 2006 FY | 35.41 Million CNY | 51.19% |
| 2006 Q2 | 29.87 Million CNY | 5.01% |
| 2005 Q2 | 26.37 Million CNY | -39.22% |
| 2005 Q1 | 43.38 Million CNY | 52.89% |
| 2005 Q4 | 23.42 Million CNY | -5.28% |
| 2005 FY | 23.42 Million CNY | -17.47% |
| 2005 Q3 | 24.72 Million CNY | -6.25% |
| 2004 Q3 | 15.85 Million CNY | -10.43% |
| 2004 Q2 | 17.69 Million CNY | 0.0% |
| 2004 FY | 28.37 Million CNY | -22.84% |
| 2004 Q4 | 28.37 Million CNY | 79.03% |
| 2003 Q4 | 36.78 Million CNY | 0.0% |
| 2003 FY | 36.78 Million CNY | 113.5% |
| 2002 FY | 17.22 Million CNY | 58.96% |
| 2001 FY | 10.83 Million CNY | 0.0% |